Mkt Cap$2.29T-1.02%
24h Vol$87.18B
BTC Dom56.0%
ETH Dom9.2%
F&G15Extreme Fear
BTC$63,875.00-1.14% ETH$1,740.21-1.36% USDT$0.9991+0.00% BNB$588.67-2.27% USDC$0.9997-0.01% XRP$1.16-2.13% SOL$70.83-1.52% TRX$0.32+0.13% FIGR_HELOC$1.02-1.42% HYPE$71.38+0.58% DOGE$0.0844-1.32% USDS$0.9997+0.00% RAIN$0.0145+3.62% LEO$9.63+0.68% XLM$0.2356+6.99% ZEC$468.23-5.77% BTC$63,875.00-1.14% ETH$1,740.21-1.36% USDT$0.9991+0.00% BNB$588.67-2.27% USDC$0.9997-0.01% XRP$1.16-2.13% SOL$70.83-1.52% TRX$0.32+0.13% FIGR_HELOC$1.02-1.42% HYPE$71.38+0.58% DOGE$0.0844-1.32% USDS$0.9997+0.00% RAIN$0.0145+3.62% LEO$9.63+0.68% XLM$0.2356+6.99% ZEC$468.23-5.77%
News

Earnings

Total Stories
1,191
Section
Earnings
Eli Lilly's Q4 2024 Revenue Surges by 45% to $13.53 Billion in Q4 2024
Earnings

Eli Lilly’s Q4 2024 Revenue Surges by 45% to $13.53 Billion

Eli Lilly and Company (NYSE: LLY) reported a robust revenue growth of 45% in Q4 2024, reaching $13.53 billion, driven by increased volume from key products.

Tim FriesFeb 6, 20254 min read